ACE and chronic kidney disease: In addition, a possible reason why a low level of calcium was associated with a high risk of AKI only in patients who did not receive CCB or ACE inhibitor therapy might be that these antihypertensive agents can reduce the concentration of cytosolic calcium and prevent some of the pathogenic mechanisms involved in kidney injury, thereby reducing chronic kidney disease (CKD) progression (43, 44).